FNArena Distribution Partnership With Pitt Street Research
Pitt Street Research provides issuer-sponsored equity research on companies that are publicly traded on the Australian Securities Exchange (ASX). Our firm, based in Sydney, was founded on the conviction that investors in ASX-listed companies need high quality, detailed research more than ever, but that less and less such research is available from the conventional investment banks and stockbroking firms. Our issuer-sponsored model makes that research available in a format that is easily accessible to institutional and private investors alike.
FNArena is acting in its capability of providing additional distribution and reach to institutional and retail investors worldwide. We have no involvement in Pitt Street Research’s decision making process about which companies are selected, including the frequency, timing or depth of research provided.
Research reports are provided for information purposes only. Nothing on this section should be seen as an invitation to purchase equities or any other investment instruments. Investors should always consult with a professional before making any investment decision.
The availability of research reports via this section does not preclude FNArena journalists from independently reporting on it. Neither distribution or reporting implies endorsement by FNArena.
IBX
Imagion Biosystems, Strong Financing In Place To Support Execution Strategy
01 Jul 2020 / Healthcare
For questions and/or feedback:
info@fnarena.com
marc.kennis@pittstreetresearch.com
To visit researchers’ website: www.pittstreetresearch.com